Vanguard Personalized Indexing Management
EDIT icon

Vanguard Personalized Indexing Management’s Editas Medicine EDIT Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$124K Sell
38,305
-1,371
-3% -$4.01K ﹤0.01% 2018
2026
Q1 		$98K Sell
39,676
-1,368
-3% -$2.9K ﹤0.01% 1948
2025
Q4 		$84.1K Hold
41,044
– – ﹤0.01% 1827
2025
Q3 		$142K Sell
41,044
-322
-0.8% -$899 ﹤0.01% 1764
2025
Q2 		$91K Buy
41,366
+14,765
+56% +$24.2K ﹤0.01% 1755
2025
Q1 		$30.9K Buy
26,601
+16,032
+152% +$23.6K ﹤0.01% 1724
2024
Q4 		$13.4K Sell
10,569
-2,691
-20% -$6.86K ﹤0.01% 1791
2024
Q3 		$45.2K Buy
+13,260
New +$57.7K ﹤0.01% 1686

Other funds holding EDIT

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Vanguard Personalized Indexing Management's EDIT Position: Q2 2026 in Review

Vanguard Personalized Indexing Management reduced its Editas Medicine (EDIT) stake by 3.5% in Q2 2026, selling an estimated $4.01K and leaving 38,305 shares worth $124K. The position accounts for ﹤0.01% of the portfolio, ranked #2018.

Vanguard Personalized Indexing Management first reported a position in EDIT in Q3 2024 and has held it in 8 quarters since. The position peaked at $142K in Q3 2025. 214 funds tracked by Wall St. Rank hold EDIT as of Q2 2026.

  • Vanguard Personalized Indexing Management held 38,305 shares of Editas Medicine worth $124K as of Q2 2026.
  • Vanguard Personalized Indexing Management sold 1,371 Editas Medicine shares in Q2 2026, an estimated $4.01K.
  • Editas Medicine made up ﹤0.01% of Vanguard Personalized Indexing Management's portfolio in Q2 2026, its #2018 holding.
  • Vanguard Personalized Indexing Management first reported a position in Editas Medicine in Q3 2024 and has held it in 8 quarters since.
  • Vanguard Personalized Indexing Management's Editas Medicine position peaked at $142K in Q3 2025.
  • 214 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2026.

Based on Vanguard Personalized Indexing Management's 13F filing for Q2 2026, filed 11 Aug 2026.